Type
Feitosa MSC, Santos GPJ, Cerqueira SRPS, Rodrigues GL, da Mota LMH, Gomes CM. Can Leprosy Reaction States Mimic Symptoms of Fibromyalgia? A Cross-Sectional Analytical Study. Frontiers in medicine [Internet]. 2022;9:870584. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082667/pdf/fmed-09-870584.pdf
Type
Malhotra KP, Husain N. Laboratory perspectives for Leprosy: Diagnostic, prognostic and predictive tools. Indian journal of pathology & microbiology [Internet]. 2022;65(Supplement):S300-S309. Available from: https://ijpmonline.org/article.asp?issn=0377-4929;year=2022;volume=65;issue=5;spage=300;epage=309;aulast=Malhotra;type=3
Type
de Souza BJ, Mendes MA, da Silva GMS, Sammarco-Rosa P, de Moraes MO, Jardim MR, et al. Gene Expression Profile of Mycobacterium leprae Contribution in the Pathology of Leprosy Neuropathy. Frontiers in medicine [Internet]. 2022;9:861586. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051340/pdf/fmed-09-861586.pdf
Type
Yang J, Li X, Sun Y, Zhang L, Jin G, Li G, et al. Global epidemiology of leprosy from 2010 to 2020: A systematic review and meta-analysis of the proportion of sex, type, grade 2 deformity and age. Pathogens and global health. 2022;:1-10.
Type
Shravani B, Ganguly S, Shukla AK, Chhabra N, Prabha N, Sachdev D, et al. Grade 2 disability among leprosy patients: A pilot study from an endemic area of Central India. Journal of family medicine and primary care [Internet]. 2022;11(4):1416-1420. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067199/pdf/JFMPC-11-1416.pdf
Type
Kabo AK, Kaman K, Doungous DM, Ouedraogo L, Abakar M, Godreuil S, et al. [Epidemiology of leprosy in Chad from 2015 to 2019]. The Pan African medical journal [Internet]. 2022;41:120. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994465/pdf/PAMJ-41-120.pdf
Type
Aubry A, Rosa S, Chauffour A, Fletcher L, Cambau E, Avanzi C. Drug resistance in leprosy: an update following 70 years of chemotherapy. Infectious diseases now [Internet]. 2022;. Available from: https://www.sciencedirect.com/science/article/pii/S2666991922000665
Type
de Oliveira ALG, Chaves AT, Cardoso MS, Pinheiro GRG, Antunes DE, Grossi MA de F, et al. Reduced vitamin D receptor (VDR) and cathelicidin antimicrobial peptide (CAMP) gene expression contribute to the maintenance of inflammatory immune response in leprosy patients. Microbes and infection. 2022;:104981.
Type
Pinheiro LCS, Borges JC, Campos VR, Dantas LC. An Overview of Treatment Guidelines and Methods of Synthesis of Drugs Used in Leprosy Chemotherapy. Mini reviews in medicinal chemistry. 2022;.
Type
Andrade ESN, Brandão JG, da Silva JS, Coriolano CRF, Rosa PS, Moraes MO, et al. Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan. Antimicrobial agents and chemotherapy. 2022;:e0217021.